MedPath

厦门力卓药业有限公司

Ownership
-
Established
2003-05-26
Employees
-
Market Cap
-
Website
www.lizhuopharma.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

13

NMPA:13

Drug Approvals

Nicorandil Tablets

Product Name
尼可地尔片
Approval Number
国药准字H20253041
Approval Date
Jan 2, 2025
NMPA

Levofloxacin Hydrochloride Tablets

Product Name
盐酸左氧氟沙星片
Approval Number
国药准字H20094051
Approval Date
Aug 14, 2024
NMPA

小儿清热止咳口服液

Approval Number
国药准字Z20093507
Approval Date
Feb 29, 2024
NMPA

Simvastatin Capsules

Product Name
辛伐他汀胶囊
Approval Number
国药准字H20093998
Approval Date
Feb 29, 2024
NMPA

Perfluoropropane-albumin Microspheres for Injection

Product Name
注射用全氟丙烷人血白蛋白微球
Approval Number
国药准字S20191000
Approval Date
Feb 29, 2024
NMPA

更年灵胶囊

Approval Number
国药准字Z20083020
Approval Date
Apr 13, 2023
NMPA

跌打活血散

Approval Number
国药准字Z20093538
Approval Date
Jul 18, 2022
NMPA

Levofloxacin Tablets

Product Name
左氧氟沙星片
Approval Number
国药准字H20213919
Approval Date
Dec 8, 2021
NMPA

通脉口服液

Approval Number
国药准字Z20063895
Approval Date
Apr 7, 2021
NMPA

玉屏风丸

Approval Number
国药准字Z20063869
Approval Date
Apr 7, 2021
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.